MYCN and cancer: Several TFs (e.g., MYC, MYCN, BCL6, p53) have been exhaustively studied and characterized as master regulators in distinct types of tumors [3,5,6,7,8,9,10], a fact that underscores the current understanding that describes cancer as a deleterious outcome of cellular gene expression dysregulation.